Viewing Study NCT02130466

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 4:28 PM

Ignite Modification Date: 2025-12-29 @ 9:00 PM

Study NCT ID: NCT02130466

Status: COMPLETED

Last Update Posted: 2022-08-01

First Post: 2014-05-01

Is Gene Therapy: True

Has Adverse Events: True

Brief Title: A Study of the Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With Trametinib and Dabrafenib in Participants With Advanced Melanoma (MK-3475-022/KEYNOTE-022)

Sponsor: Merck Sharp & Dohme LLC

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module